Company Profile
NovoCure Limited Stock Price, News & Catalysts
- Ticker:
- NVCR
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- Switzerland
Stock performance
16.76 USD (-1.99%)
Close
Last updated: August 24, 2026
1.83B USD
Market cap
Why the stock is moving
As of Aug 24, 2026, NVCR closed down 1.99% at $16.76. No new same-company headline was identified in the current news window.
Company overview
Business overview
NovoCure is a medical technology company focused on tumor treating fields, a non-invasive cancer treatment modality. Its business is centered on device-based oncology treatment rather than pharmaceuticals.
Geographic Base and Sector Classification
NovoCure is headquartered in Switzerland and listed on NASDAQ. It sits in oncology medtech rather than biotechnology.
Business Model Characteristics
The company depends on adoption of tumor treating fields, reimbursement, and clinical workflow integration. Investors watch usage growth, market expansion, and the breadth of oncology indications.
Position Within the Biotechnology Landscape
NovoCure occupies a unique device-oncology niche within healthcare. It is not biotech, but it is highly relevant to cancer treatment innovation.
Future catalysts
- NovoCure’s catalysts are TTFields adoption, reimbursement, and continued execution across tumor types. The company’s stock usually responds when utilization broadens and evidence strengthens.
Recent news
- 01
- 02
- 03
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of NovoCure Limited (NVCR)?
NovoCure Limited (NVCR) most recently closed at 16.76 USD, a -1.99% move versus the previous session.
What is the market cap of NovoCure Limited (NVCR)?
NovoCure Limited currently has a market capitalization of 1.83B USD on BioPharmSignal.
What does NovoCure Limited do?
NovoCure is a medical technology company focused on tumor treating fields, a non-invasive cancer treatment modality. Its business is centered on device-based oncology treatment rather than pharmaceuticals.
On which exchange is NVCR stock listed?
NovoCure Limited (NVCR) is associated with NASDAQ, Switzerland, Biopharma.
What is NovoCure?
NovoCure’s catalysts are TTFields adoption, reimbursement, and continued execution across tumor types.
Which conditions is NovoCure Limited targeting with NovoCure?
NovoCure Limited is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
How does NovoCure Limited describe recent progress with NovoCure?
NovoCure’s catalysts are TTFields adoption, reimbursement, and continued execution across tumor types.
What is TTFields?
NovoCure’s catalysts are TTFields adoption, reimbursement, and continued execution across tumor types.